Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001171843-21-003886
Filing Date
2021-05-28
Accepted
2021-05-28 16:27:38
Documents
3
Effectiveness Date
2021-05-28

Document Format Files

Seq Description Document Type Size
1 S-8 s8_052821sip.htm S-8 50573
2 EXHIBIT 5.1 exh_51.htm EX-5.1 6394
3 EXHIBIT 23.1 exh_231.htm EX-23.1 2084
  Complete submission text file 0001171843-21-003886.txt   60087
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-256625 | Film No.: 21980681
SIC: 2836 Biological Products, (No Diagnostic Substances)